Development of specific Kinase Inhibitors for the Treatment of Inflammatory diseases

被引：0

作者：

Neubauer, G. ^{[1
]}

机构：

[1] Cellzome, Heidelberg, Germany

来源：

ARZNEIMITTELFORSCHUNG-DRUG RESEARCH | 2012年 / 62卷

关键词：

MECHANISMS; CELLS;

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：S18 / S19

页数：2

共 50 条

[41] Development of TLR inhibitors for the treatment of autoimmune diseases
Barrat, Franck J.
Coffman, Robert L.
[J]. IMMUNOLOGICAL REVIEWS, 2008, 223 : 271 - 283
[42] Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK2) as Treatment for Inflammatory Diseases
Abdel-Magid, Ahmed F.
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (09): : 1421 - 1423
[43] Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases
Xie, Zhouling
Yang, Xiaoxiao
Duan, Yajun
Han, Jihong
Liao, Chenzhong
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (03) : 1283 - 1345
[44] PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases
Levitzki, A
[J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (04) : 229 - 235
[45] Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases
Okumura, Naoki
Kinoshita, Shigeru
Koizumi, Noriko
[J]. JOURNAL OF OPHTHALMOLOGY, 2017, 2017
[46] Dual leucine zipper kinase inhibitors for the treatment of neurodegenerative diseases
Siu, Michael
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[47] Development of potent inhibitors of a critical mediator of autoimmune and inflammatory diseases
Al-Abed, Yousef
Cheng, Kai Fan
Dabideen, Darrin
Ochani, Mahendar
Aljabari, Bayan
Pavlov, Valentin A.
Lolis, Elias
Miller, Edmund J.
[J]. DRUGS OF THE FUTURE, 2007, 32 : 27 - 27
[48] Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders
Roskoski, Robert, Jr.
[J]. PHARMACOLOGICAL RESEARCH, 2022, 183
[49] The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment
Kim, Jin-Woo
Kim, Su-Young
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
[50] Targeting Janus kinase 3 in the treatment of leukemia and inflammatory diseases
Cetkovic-Cvrlje, M
Uckun, FM
[J]. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2004, 52 (02) : 69 - 82

← 1 2 3 4 5 →